15 articles for B Kellam
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis, Biological Evaluation, and Utility of Fluorescent Ligands Targeting theµ-Opioid Receptor.

University of Nottingham
Synthesis of New DPP-4 Inhibitors Based on a Novel Tricyclic Scaffold.

University Park Nottingham
5-Deazaflavin derivatives as inhibitors of p53 ubiquitination by HDM2.

University of Nottingham
Synthesis and in vitro and in vivo characterization of highlyß1-selectiveß-adrenoceptor partial agonists.

University of Nottingham
Highly potent and selective fluorescent antagonists of the human adenosine A3 receptor based on the 1,2,4-triazolo[4,3-a]quinoxalin-1-one scaffold.

University of Nottingham
Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for humanß-adrenoceptors.

University of Nottingham
New fluorescent adenosine A1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cells.

University of Nottingham
Drug-like Antagonists of P2Y Receptors-From Lead Identification to Drug Development.

University of Nottingham
Optimization of Peptide Linker-Based Fluorescent Ligands for the Histamine H

University of Nottingham Biodiscovery Institute
Chemical modification of the naphthoyl 3-position of JWH-015: in search of a fluorescent probe to the cannabinoid CB2 receptor.

University of Nottingham
Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A

Monash University
Synthesis and matched molecular pair analysis of covalent reversible inhibitors of the cysteine protease CPB.

S£O Carlos Institute of Chemistry-University of S£O Paulo (Iqsc-Usp)
Structure-Kinetic Profiling of Haloperidol Analogues at the Human Dopamine D

University of Nottingham
Synthesis and Evaluation of the First Fluorescent Antagonists of the Human P2Y

University Park Nottingham
Design and Elaboration of a Tractable Tricyclic Scaffold To Synthesize Druglike Inhibitors of Dipeptidyl Peptidase-4 (DPP-4), Antagonists of the C-C Chemokine Receptor Type 5 (CCR5), and Highly Potent and Selective Phosphoinositol-3 Kinaseδ (PI3Kδ) Inhibitors.

University Park Nottingham